semaglutide news 2025 november 28 A network meta-analysis backed weight-loss benefits with several GLP What the Obesity Drugmakers Expect

In a Planet Money report, one user found their access denied after improving too much with the medication

Michael Mina, eMed Chief Science Officer

Sermorelin is a prescription medication intended for specific medical conditions, namely growth hormone deficiency or related diagnoses confirmed by a physician

Committing to long-term lifestyle changes is crucial to sustainable weight loss and well-being

Does the Alliance for Pharmacy Compounding still insist that the FTC's jurisdiction for advertisements that market-compounded medication is what matters for ads like this

As our mechanistic understanding deepensthrough integrated omics and refined RNA-binding assaysnovel epitranscriptomic targets will undoubtedly emerge, offering promising avenues for precision immunotherapy